Therapeutic areas for approved chemical drug IND applications in China 2021
approved 1,310 Investigational New Drug (IND) applications of chemical drugs. Almost half of all approvals were granted to antineoplastic drugs. A considerable number of drugs treating skin diseases, Ear, Nose and Throat (ENT) disorders, circulatory diseases, and digestive system conditions were also approved for general use.
In 2021, the Chinese Center for Drug Evaluation of the National Medical Products Administration (NMPA)